Tissue-engineered 3D cancer-in-bone modeling: silk and PUR protocols.
Document Type
Article
Publication Date
1-2016
Institution/Department
MMCRI
Journal Title
BoneKEy reports
Abstract
Cancers that metastasize or grow in the bone marrow are typically considered incurable and cause extensive damage to the bone and bone marrow. The bone is a complex, dynamic, three-dimensional (3D) environment composed of a plethora of cells that may contribute to, or constrain, the growth of tumor cells and development of bone disease. The development of safe and effective drugs is currently hampered by pre-clinical two-dimensional (2D) models whose poor predictive power does not accurately predict the success or failure of therapeutics. These inadequate models often result in drugs proceeding through extensive pre-clinical studies only to fail clinically. Consistently, 3D co-culture systems prove superior to 2D mono-cultures in modeling
ISSN
2047-6396
First Page
842
Last Page
842
Recommended Citation
Dadwal, Ushashi; Falank, Carolyne; Fairfield, Heather; Linehan, Sarah; Rosen, Clifford J; Kaplan, David L; Sterling, Julie; and Reagan, Michaela R, "Tissue-engineered 3D cancer-in-bone modeling: silk and PUR protocols." (2016). MaineHealth Maine Medical Center. 187.
https://knowledgeconnection.mainehealth.org/mmc/187